nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—ABCB1—Tacrolimus—atopic dermatitis	0.11	0.231	CbGbCtD
Dabigatran etexilate—ABCB1—Loratadine—atopic dermatitis	0.0805	0.169	CbGbCtD
Dabigatran etexilate—ABCB1—Methylprednisolone—atopic dermatitis	0.0737	0.155	CbGbCtD
Dabigatran etexilate—ABCB1—Betamethasone—atopic dermatitis	0.0479	0.1	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisolone—atopic dermatitis	0.0473	0.0991	CbGbCtD
Dabigatran etexilate—ABCB1—Hydrocortisone—atopic dermatitis	0.0448	0.094	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisone—atopic dermatitis	0.0446	0.0936	CbGbCtD
Dabigatran etexilate—ABCB1—Dexamethasone—atopic dermatitis	0.0279	0.0584	CbGbCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—FCER1A—atopic dermatitis	0.00196	0.102	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—CCR3—atopic dermatitis	0.000957	0.0496	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—TLR2—atopic dermatitis	0.000757	0.0392	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IL18—atopic dermatitis	0.000582	0.0301	CbGpPWpGaD
Dabigatran etexilate—Headache—Loratadine—atopic dermatitis	0.000579	0.00115	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000575	0.00114	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000573	0.00114	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000572	0.00113	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisolone—atopic dermatitis	0.00057	0.00113	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Triamcinolone—atopic dermatitis	0.00057	0.00113	CcSEcCtD
Dabigatran etexilate—Asthenia—Mometasone—atopic dermatitis	0.000569	0.00113	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.000569	0.00113	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000568	0.00113	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisolone—atopic dermatitis	0.000568	0.00113	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Tacrolimus—atopic dermatitis	0.000563	0.00112	CcSEcCtD
Dabigatran etexilate—Pruritus—Mometasone—atopic dermatitis	0.000561	0.00111	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000557	0.00111	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Tacrolimus—atopic dermatitis	0.000556	0.0011	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000554	0.0011	CcSEcCtD
Dabigatran etexilate—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000549	0.00109	CcSEcCtD
Dabigatran etexilate—Nausea—Loratadine—atopic dermatitis	0.000549	0.00109	CcSEcCtD
Dabigatran etexilate—Epistaxis—Triamcinolone—atopic dermatitis	0.000548	0.00109	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000545	0.00108	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000545	0.00108	CcSEcCtD
Dabigatran etexilate—Fatigue—Tacrolimus—atopic dermatitis	0.000544	0.00108	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Mometasone—atopic dermatitis	0.000543	0.00108	CcSEcCtD
Dabigatran etexilate—Constipation—Tacrolimus—atopic dermatitis	0.00054	0.00107	CcSEcCtD
Dabigatran etexilate—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000528	0.00105	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.000526	0.00104	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Triamcinolone—atopic dermatitis	0.000525	0.00104	CcSEcCtD
Dabigatran etexilate—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000524	0.00104	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000523	0.00104	CcSEcCtD
Dabigatran etexilate—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000523	0.00104	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Triamcinolone—atopic dermatitis	0.000522	0.00104	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000521	0.00103	CcSEcCtD
Dabigatran etexilate—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00052	0.00103	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.00052	0.00103	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.00052	0.00103	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Betamethasone—atopic dermatitis	0.000517	0.00103	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Dexamethasone—atopic dermatitis	0.000517	0.00103	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000516	0.00102	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000512	0.00102	CcSEcCtD
Dabigatran etexilate—Vomiting—Mometasone—atopic dermatitis	0.000504	0.001	CcSEcCtD
Dabigatran etexilate—Urticaria—Tacrolimus—atopic dermatitis	0.000502	0.000995	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000501	0.000993	CcSEcCtD
Dabigatran etexilate—Rash—Mometasone—atopic dermatitis	0.0005	0.000992	CcSEcCtD
Dabigatran etexilate—Dermatitis—Mometasone—atopic dermatitis	0.0005	0.000991	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Tacrolimus—atopic dermatitis	0.000499	0.00099	CcSEcCtD
Dabigatran etexilate—Headache—Mometasone—atopic dermatitis	0.000497	0.000986	CcSEcCtD
Dabigatran etexilate—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000493	0.000979	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000483	0.000959	CcSEcCtD
Dabigatran etexilate—Malnutrition—Hydrocortisone—atopic dermatitis	0.000483	0.000957	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Betamethasone—atopic dermatitis	0.000476	0.000944	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Dexamethasone—atopic dermatitis	0.000476	0.000944	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Dexamethasone—atopic dermatitis	0.000474	0.00094	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Betamethasone—atopic dermatitis	0.000474	0.00094	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methylprednisolone—atopic dermatitis	0.000473	0.000937	CcSEcCtD
Dabigatran etexilate—Nausea—Mometasone—atopic dermatitis	0.000471	0.000935	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methylprednisolone—atopic dermatitis	0.00047	0.000933	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000469	0.000931	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000465	0.000923	CcSEcCtD
Dabigatran etexilate—F2—Syndecan-4-mediated signaling events—CCL5—atopic dermatitis	0.000463	0.0239	CbGpPWpGaD
Dabigatran etexilate—Malnutrition—Methylprednisolone—atopic dermatitis	0.000453	0.000899	CcSEcCtD
Dabigatran etexilate—Asthenia—Tacrolimus—atopic dermatitis	0.000453	0.000899	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000453	0.000899	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisolone—atopic dermatitis	0.000451	0.000896	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Prednisone—atopic dermatitis	0.00045	0.000893	CcSEcCtD
Dabigatran etexilate—Pruritus—Tacrolimus—atopic dermatitis	0.000447	0.000886	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisolone—atopic dermatitis	0.000443	0.000879	CcSEcCtD
Dabigatran etexilate—Angioedema—Hydrocortisone—atopic dermatitis	0.000441	0.000875	CcSEcCtD
Dabigatran etexilate—Back pain—Triamcinolone—atopic dermatitis	0.00044	0.000872	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisolone—atopic dermatitis	0.000434	0.000862	CcSEcCtD
Dabigatran etexilate—Syncope—Hydrocortisone—atopic dermatitis	0.000433	0.000859	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Tacrolimus—atopic dermatitis	0.000432	0.000857	CcSEcCtD
Dabigatran etexilate—Angiopathy—Dexamethasone—atopic dermatitis	0.00043	0.000852	CcSEcCtD
Dabigatran etexilate—Angiopathy—Betamethasone—atopic dermatitis	0.00043	0.000852	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisolone—atopic dermatitis	0.000427	0.000846	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000424	0.000841	CcSEcCtD
Dabigatran etexilate—Dizziness—Tacrolimus—atopic dermatitis	0.000417	0.000828	CcSEcCtD
Dabigatran etexilate—Hypertension—Hydrocortisone—atopic dermatitis	0.000417	0.000827	CcSEcCtD
Dabigatran etexilate—Angioedema—Triamcinolone—atopic dermatitis	0.000415	0.000824	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisone—atopic dermatitis	0.000415	0.000822	CcSEcCtD
Dabigatran etexilate—Angioedema—Methylprednisolone—atopic dermatitis	0.000414	0.000822	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisone—atopic dermatitis	0.000412	0.000818	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000408	0.000809	CcSEcCtD
Dabigatran etexilate—Syncope—Triamcinolone—atopic dermatitis	0.000407	0.000808	CcSEcCtD
Dabigatran etexilate—Syncope—Methylprednisolone—atopic dermatitis	0.000407	0.000807	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Prednisone—atopic dermatitis	0.000405	0.000804	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000403	0.0008	CcSEcCtD
Dabigatran etexilate—Vomiting—Tacrolimus—atopic dermatitis	0.000401	0.000796	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000399	0.000792	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000398	0.000791	CcSEcCtD
Dabigatran etexilate—Rash—Tacrolimus—atopic dermatitis	0.000398	0.00079	CcSEcCtD
Dabigatran etexilate—Dermatitis—Tacrolimus—atopic dermatitis	0.000398	0.000789	CcSEcCtD
Dabigatran etexilate—Shock—Prednisolone—atopic dermatitis	0.000397	0.000787	CcSEcCtD
Dabigatran etexilate—Cough—Triamcinolone—atopic dermatitis	0.000396	0.000787	CcSEcCtD
Dabigatran etexilate—Headache—Tacrolimus—atopic dermatitis	0.000395	0.000785	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000394	0.000781	CcSEcCtD
Dabigatran etexilate—Hypertension—Triamcinolone—atopic dermatitis	0.000392	0.000778	CcSEcCtD
Dabigatran etexilate—Hypertension—Methylprednisolone—atopic dermatitis	0.000391	0.000777	CcSEcCtD
Dabigatran etexilate—Infection—Hydrocortisone—atopic dermatitis	0.000391	0.000776	CcSEcCtD
Dabigatran etexilate—Shock—Hydrocortisone—atopic dermatitis	0.000387	0.000769	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000386	0.000766	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methylprednisolone—atopic dermatitis	0.000386	0.000766	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000383	0.00076	CcSEcCtD
Dabigatran etexilate—Skin disorder—Hydrocortisone—atopic dermatitis	0.000383	0.000759	CcSEcCtD
Dabigatran etexilate—Angioedema—Betamethasone—atopic dermatitis	0.000377	0.000747	CcSEcCtD
Dabigatran etexilate—Angioedema—Dexamethasone—atopic dermatitis	0.000377	0.000747	CcSEcCtD
Dabigatran etexilate—Nausea—Tacrolimus—atopic dermatitis	0.000375	0.000744	CcSEcCtD
Dabigatran etexilate—Angiopathy—Prednisone—atopic dermatitis	0.000374	0.000742	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Prednisone—atopic dermatitis	0.000373	0.000739	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000371	0.000736	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.00037	0.000734	CcSEcCtD
Dabigatran etexilate—Syncope—Dexamethasone—atopic dermatitis	0.00037	0.000733	CcSEcCtD
Dabigatran etexilate—Syncope—Betamethasone—atopic dermatitis	0.00037	0.000733	CcSEcCtD
Dabigatran etexilate—Infection—Triamcinolone—atopic dermatitis	0.000368	0.000731	CcSEcCtD
Dabigatran etexilate—Hypotension—Hydrocortisone—atopic dermatitis	0.000368	0.00073	CcSEcCtD
Dabigatran etexilate—Infection—Methylprednisolone—atopic dermatitis	0.000368	0.000729	CcSEcCtD
Dabigatran etexilate—Shock—Triamcinolone—atopic dermatitis	0.000365	0.000724	CcSEcCtD
Dabigatran etexilate—Shock—Methylprednisolone—atopic dermatitis	0.000364	0.000722	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000363	0.00072	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Betamethasone—atopic dermatitis	0.000362	0.000719	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000362	0.000719	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methylprednisolone—atopic dermatitis	0.000359	0.000713	CcSEcCtD
Dabigatran etexilate—Malnutrition—Prednisone—atopic dermatitis	0.000359	0.000712	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000359	0.000712	CcSEcCtD
Dabigatran etexilate—UGT1A9—PPAR Alpha Pathway—PPARA—atopic dermatitis	0.000358	0.0185	CbGpPWpGaD
Dabigatran etexilate—Hypertension—Dexamethasone—atopic dermatitis	0.000356	0.000706	CcSEcCtD
Dabigatran etexilate—Hypertension—Betamethasone—atopic dermatitis	0.000356	0.000706	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.000348	0.018	CbGpPWpGaD
Dabigatran etexilate—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000347	0.000688	CcSEcCtD
Dabigatran etexilate—Hypotension—Methylprednisolone—atopic dermatitis	0.000346	0.000686	CcSEcCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IFNG—atopic dermatitis	0.000341	0.0177	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.00034	0.000675	CcSEcCtD
Dabigatran etexilate—Fatigue—Hydrocortisone—atopic dermatitis	0.00034	0.000674	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000338	0.00067	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000337	0.000669	CcSEcCtD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—SELE—atopic dermatitis	0.000337	0.0174	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000336	0.000668	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000336	0.000668	CcSEcCtD
Dabigatran etexilate—Infection—Betamethasone—atopic dermatitis	0.000334	0.000663	CcSEcCtD
Dabigatran etexilate—Infection—Dexamethasone—atopic dermatitis	0.000334	0.000663	CcSEcCtD
Dabigatran etexilate—Anaemia—Prednisone—atopic dermatitis	0.000332	0.000658	CcSEcCtD
Dabigatran etexilate—Shock—Betamethasone—atopic dermatitis	0.000331	0.000657	CcSEcCtD
Dabigatran etexilate—Shock—Dexamethasone—atopic dermatitis	0.000331	0.000657	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Triamcinolone—atopic dermatitis	0.000331	0.000656	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Betamethasone—atopic dermatitis	0.00033	0.000655	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00033	0.000655	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000329	0.000654	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000329	0.000654	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisone—atopic dermatitis	0.000328	0.000651	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Triamcinolone—atopic dermatitis	0.000326	0.000648	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000326	0.000646	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000322	0.000639	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisone—atopic dermatitis	0.000322	0.000639	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisolone—atopic dermatitis	0.00032	0.000636	CcSEcCtD
Dabigatran etexilate—Fatigue—Triamcinolone—atopic dermatitis	0.00032	0.000634	CcSEcCtD
Dabigatran etexilate—Fatigue—Methylprednisolone—atopic dermatitis	0.000319	0.000633	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.000319	0.0165	CbGpPWpGaD
Dabigatran etexilate—Loss of consciousness—Prednisone—atopic dermatitis	0.000316	0.000626	CcSEcCtD
Dabigatran etexilate—Hypotension—Betamethasone—atopic dermatitis	0.000314	0.000624	CcSEcCtD
Dabigatran etexilate—Hypotension—Dexamethasone—atopic dermatitis	0.000314	0.000624	CcSEcCtD
Dabigatran etexilate—Urticaria—Hydrocortisone—atopic dermatitis	0.000313	0.000621	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000311	0.000618	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00031	0.0161	CbGpPWpGaD
Dabigatran etexilate—Hypertension—Prednisone—atopic dermatitis	0.00031	0.000615	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000307	0.000608	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000307	0.000608	CcSEcCtD
Dabigatran etexilate—Arthralgia—Prednisone—atopic dermatitis	0.000306	0.000606	CcSEcCtD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IL1B—atopic dermatitis	0.000304	0.0158	CbGpPWpGaD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000304	0.000602	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000303	0.0006	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisolone—atopic dermatitis	0.000297	0.000589	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Dexamethasone—atopic dermatitis	0.000296	0.000588	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Betamethasone—atopic dermatitis	0.000296	0.000588	CcSEcCtD
Dabigatran etexilate—Urticaria—Triamcinolone—atopic dermatitis	0.000295	0.000584	CcSEcCtD
Dabigatran etexilate—Urticaria—Methylprednisolone—atopic dermatitis	0.000294	0.000583	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisone—atopic dermatitis	0.000293	0.000581	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000292	0.00058	CcSEcCtD
Dabigatran etexilate—Infection—Prednisone—atopic dermatitis	0.000291	0.000578	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00029	0.000576	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00029	0.000576	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.00029	0.000576	CcSEcCtD
Dabigatran etexilate—Fatigue—Dexamethasone—atopic dermatitis	0.00029	0.000576	CcSEcCtD
Dabigatran etexilate—Fatigue—Betamethasone—atopic dermatitis	0.00029	0.000576	CcSEcCtD
Dabigatran etexilate—Shock—Prednisone—atopic dermatitis	0.000288	0.000572	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Prednisone—atopic dermatitis	0.000287	0.00057	CcSEcCtD
Dabigatran etexilate—Skin disorder—Prednisone—atopic dermatitis	0.000285	0.000565	CcSEcCtD
Dabigatran etexilate—Asthenia—Hydrocortisone—atopic dermatitis	0.000283	0.000561	CcSEcCtD
Dabigatran etexilate—Pruritus—Hydrocortisone—atopic dermatitis	0.000279	0.000553	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.000278	0.0144	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000275	0.000546	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000275	0.000546	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000273	0.000542	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000273	0.000541	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000269	0.000535	CcSEcCtD
Dabigatran etexilate—Urticaria—Betamethasone—atopic dermatitis	0.000267	0.00053	CcSEcCtD
Dabigatran etexilate—Urticaria—Dexamethasone—atopic dermatitis	0.000267	0.00053	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000267	0.00053	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisolone—atopic dermatitis	0.000267	0.000529	CcSEcCtD
Dabigatran etexilate—Asthenia—Triamcinolone—atopic dermatitis	0.000266	0.000528	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dexamethasone—atopic dermatitis	0.000266	0.000528	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Betamethasone—atopic dermatitis	0.000266	0.000528	CcSEcCtD
Dabigatran etexilate—Asthenia—Methylprednisolone—atopic dermatitis	0.000265	0.000527	CcSEcCtD
Dabigatran etexilate—Pruritus—Triamcinolone—atopic dermatitis	0.000262	0.000521	CcSEcCtD
Dabigatran etexilate—Pruritus—Methylprednisolone—atopic dermatitis	0.000262	0.000519	CcSEcCtD
Dabigatran etexilate—Dizziness—Hydrocortisone—atopic dermatitis	0.00026	0.000517	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Prednisone—atopic dermatitis	0.000258	0.000512	CcSEcCtD
Dabigatran etexilate—Rash—Prednisolone—atopic dermatitis	0.000254	0.000504	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisolone—atopic dermatitis	0.000254	0.000504	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000253	0.000502	CcSEcCtD
Dabigatran etexilate—Fatigue—Prednisone—atopic dermatitis	0.000253	0.000501	CcSEcCtD
Dabigatran etexilate—Headache—Prednisolone—atopic dermatitis	0.000253	0.000501	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—IL4—atopic dermatitis	0.000251	0.013	CbGpPWpGaD
Dabigatran etexilate—Constipation—Prednisone—atopic dermatitis	0.000251	0.000497	CcSEcCtD
Dabigatran etexilate—Vomiting—Hydrocortisone—atopic dermatitis	0.00025	0.000497	CcSEcCtD
Dabigatran etexilate—Rash—Hydrocortisone—atopic dermatitis	0.000248	0.000493	CcSEcCtD
Dabigatran etexilate—Dermatitis—Hydrocortisone—atopic dermatitis	0.000248	0.000492	CcSEcCtD
Dabigatran etexilate—Headache—Hydrocortisone—atopic dermatitis	0.000247	0.000489	CcSEcCtD
Dabigatran etexilate—Dizziness—Triamcinolone—atopic dermatitis	0.000245	0.000486	CcSEcCtD
Dabigatran etexilate—Dizziness—Methylprednisolone—atopic dermatitis	0.000245	0.000485	CcSEcCtD
Dabigatran etexilate—Asthenia—Betamethasone—atopic dermatitis	0.000241	0.000479	CcSEcCtD
Dabigatran etexilate—Asthenia—Dexamethasone—atopic dermatitis	0.000241	0.000479	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Prednisone—atopic dermatitis	0.00024	0.000475	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisolone—atopic dermatitis	0.00024	0.000475	CcSEcCtD
Dabigatran etexilate—Pruritus—Betamethasone—atopic dermatitis	0.000238	0.000472	CcSEcCtD
Dabigatran etexilate—Pruritus—Dexamethasone—atopic dermatitis	0.000238	0.000472	CcSEcCtD
Dabigatran etexilate—Vomiting—Triamcinolone—atopic dermatitis	0.000236	0.000468	CcSEcCtD
Dabigatran etexilate—Vomiting—Methylprednisolone—atopic dermatitis	0.000235	0.000467	CcSEcCtD
Dabigatran etexilate—Nausea—Hydrocortisone—atopic dermatitis	0.000234	0.000464	CcSEcCtD
Dabigatran etexilate—Rash—Triamcinolone—atopic dermatitis	0.000234	0.000464	CcSEcCtD
Dabigatran etexilate—Dermatitis—Triamcinolone—atopic dermatitis	0.000234	0.000463	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000234	0.0121	CbGpPWpGaD
Dabigatran etexilate—Rash—Methylprednisolone—atopic dermatitis	0.000233	0.000463	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methylprednisolone—atopic dermatitis	0.000233	0.000462	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisone—atopic dermatitis	0.000233	0.000462	CcSEcCtD
Dabigatran etexilate—Headache—Triamcinolone—atopic dermatitis	0.000232	0.000461	CcSEcCtD
Dabigatran etexilate—Headache—Methylprednisolone—atopic dermatitis	0.000232	0.00046	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Prednisone—atopic dermatitis	0.000232	0.00046	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Dexamethasone—atopic dermatitis	0.00023	0.000457	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Betamethasone—atopic dermatitis	0.00023	0.000457	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000224	0.0116	CbGpPWpGaD
Dabigatran etexilate—F2—Post-translational protein modification—GLB1—atopic dermatitis	0.000224	0.0116	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Dexamethasone—atopic dermatitis	0.000223	0.000441	CcSEcCtD
Dabigatran etexilate—Dizziness—Betamethasone—atopic dermatitis	0.000223	0.000441	CcSEcCtD
Dabigatran etexilate—Nausea—Triamcinolone—atopic dermatitis	0.00022	0.000437	CcSEcCtD
Dabigatran etexilate—Nausea—Methylprednisolone—atopic dermatitis	0.00022	0.000436	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisone—atopic dermatitis	0.000216	0.000428	CcSEcCtD
Dabigatran etexilate—Vomiting—Betamethasone—atopic dermatitis	0.000214	0.000424	CcSEcCtD
Dabigatran etexilate—Vomiting—Dexamethasone—atopic dermatitis	0.000214	0.000424	CcSEcCtD
Dabigatran etexilate—Rash—Dexamethasone—atopic dermatitis	0.000212	0.000421	CcSEcCtD
Dabigatran etexilate—Rash—Betamethasone—atopic dermatitis	0.000212	0.000421	CcSEcCtD
Dabigatran etexilate—Dermatitis—Dexamethasone—atopic dermatitis	0.000212	0.000421	CcSEcCtD
Dabigatran etexilate—Dermatitis—Betamethasone—atopic dermatitis	0.000212	0.000421	CcSEcCtD
Dabigatran etexilate—Headache—Dexamethasone—atopic dermatitis	0.000211	0.000418	CcSEcCtD
Dabigatran etexilate—Headache—Betamethasone—atopic dermatitis	0.000211	0.000418	CcSEcCtD
Dabigatran etexilate—Asthenia—Prednisone—atopic dermatitis	0.00021	0.000417	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000208	0.0108	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Prednisone—atopic dermatitis	0.000207	0.000411	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Prednisone—atopic dermatitis	0.0002	0.000398	CcSEcCtD
Dabigatran etexilate—Nausea—Betamethasone—atopic dermatitis	0.0002	0.000397	CcSEcCtD
Dabigatran etexilate—Nausea—Dexamethasone—atopic dermatitis	0.0002	0.000397	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisone—atopic dermatitis	0.000194	0.000384	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000187	0.00967	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000187	0.00966	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Prednisone—atopic dermatitis	0.000186	0.00037	CcSEcCtD
Dabigatran etexilate—Rash—Prednisone—atopic dermatitis	0.000185	0.000367	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisone—atopic dermatitis	0.000185	0.000366	CcSEcCtD
Dabigatran etexilate—Headache—Prednisone—atopic dermatitis	0.000184	0.000364	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000183	0.00947	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL22—atopic dermatitis	0.000178	0.00921	CbGpPWpGaD
Dabigatran etexilate—Nausea—Prednisone—atopic dermatitis	0.000174	0.000345	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000166	0.00862	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000165	0.00855	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—NPS—atopic dermatitis	0.000165	0.00855	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000163	0.00844	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000163	0.00844	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00016	0.00828	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL27—atopic dermatitis	0.000159	0.00821	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	0.000155	0.00803	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000154	0.00795	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IFNG—atopic dermatitis	0.000152	0.00786	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000151	0.00779	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000148	0.00765	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000148	0.00765	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000145	0.00752	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL17—atopic dermatitis	0.000142	0.00736	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000137	0.00709	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000136	0.00707	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL1B—atopic dermatitis	0.000135	0.00701	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL2—atopic dermatitis	0.000135	0.00699	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000134	0.00695	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000132	0.00685	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000129	0.00669	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000124	0.00643	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000123	0.00635	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000123	0.00635	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000121	0.00625	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000121	0.00625	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL11—atopic dermatitis	0.000115	0.00593	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000114	0.00592	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—KIF3A—atopic dermatitis	0.000113	0.00587	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—PPARA—atopic dermatitis	0.000113	0.00584	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GLB1—atopic dermatitis	0.000112	0.00581	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000111	0.00576	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	0.00011	0.00571	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000109	0.00566	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000109	0.00566	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ADSL—atopic dermatitis	0.000108	0.00557	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000108	0.00557	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000107	0.00555	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—GLB1—atopic dermatitis	0.000106	0.00551	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000106	0.00551	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.0001	0.00519	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	9.94e-05	0.00515	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—TNF—atopic dermatitis	9.83e-05	0.00509	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL6—atopic dermatitis	9.75e-05	0.00505	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCR3—atopic dermatitis	9.34e-05	0.00484	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	9.33e-05	0.00483	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SELE—atopic dermatitis	9.14e-05	0.00473	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL22—atopic dermatitis	9.13e-05	0.00473	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCL27—atopic dermatitis	8.96e-05	0.00464	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	8.67e-05	0.00449	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—TAC1—atopic dermatitis	8.33e-05	0.00431	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—NPS—atopic dermatitis	8.33e-05	0.00431	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCR3—atopic dermatitis	8.17e-05	0.00423	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL27—atopic dermatitis	8.14e-05	0.00421	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CMA1—atopic dermatitis	8.06e-05	0.00417	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL6—atopic dermatitis	7.93e-05	0.00411	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—TNF—atopic dermatitis	7.81e-05	0.00404	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL10—atopic dermatitis	7.77e-05	0.00403	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	7.6e-05	0.00394	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL4—atopic dermatitis	7.56e-05	0.00392	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.46e-05	0.00386	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.43e-05	0.00385	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL17—atopic dermatitis	7.3e-05	0.00378	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IL5—atopic dermatitis	6.92e-05	0.00358	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.72e-05	0.00348	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL10—atopic dermatitis	6.6e-05	0.00342	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL6—atopic dermatitis	6.3e-05	0.00326	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	6.06e-05	0.00314	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL11—atopic dermatitis	5.88e-05	0.00305	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FCER2—atopic dermatitis	5.8e-05	0.003	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL5—atopic dermatitis	5.68e-05	0.00294	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL22—atopic dermatitis	5.39e-05	0.00279	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	5.38e-05	0.00278	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCR3—atopic dermatitis	5.28e-05	0.00273	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	5.13e-05	0.00266	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCR5—atopic dermatitis	5.12e-05	0.00265	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GLB1—atopic dermatitis	5.11e-05	0.00265	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADSL—atopic dermatitis	4.9e-05	0.00254	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL27—atopic dermatitis	4.81e-05	0.00249	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCR3—atopic dermatitis	4.79e-05	0.00248	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—TAC1—atopic dermatitis	4.71e-05	0.00244	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—NPS—atopic dermatitis	4.71e-05	0.00244	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCR3—atopic dermatitis	4.62e-05	0.00239	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	4.57e-05	0.00237	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IL5—atopic dermatitis	4.38e-05	0.00227	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL17—atopic dermatitis	4.31e-05	0.00223	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—NPS—atopic dermatitis	4.27e-05	0.00221	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TAC1—atopic dermatitis	4.27e-05	0.00221	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	4.25e-05	0.0022	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCR3—atopic dermatitis	4.19e-05	0.00217	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GLB1—atopic dermatitis	4.16e-05	0.00215	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	4.08e-05	0.00211	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.06e-05	0.0021	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL2—atopic dermatitis	4.06e-05	0.0021	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.02e-05	0.00208	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADSL—atopic dermatitis	3.98e-05	0.00206	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL5—atopic dermatitis	3.97e-05	0.00206	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KIF3A—atopic dermatitis	3.84e-05	0.00199	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.73e-05	0.00193	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARA—atopic dermatitis	3.64e-05	0.00189	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CMA1—atopic dermatitis	3.47e-05	0.0018	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL11—atopic dermatitis	3.47e-05	0.0018	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL10—atopic dermatitis	3.39e-05	0.00175	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—STAT6—atopic dermatitis	3.27e-05	0.00169	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCL5—atopic dermatitis	3.21e-05	0.00166	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL8—atopic dermatitis	3.1e-05	0.0016	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.08e-05	0.0016	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.03e-05	0.00157	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.96e-05	0.00153	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.94e-05	0.00152	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL5—atopic dermatitis	2.92e-05	0.00151	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCR5—atopic dermatitis	2.89e-05	0.0015	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR3—atopic dermatitis	2.83e-05	0.00147	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.73e-05	0.00141	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.65e-05	0.00137	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IL2—atopic dermatitis	2.65e-05	0.00137	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCR5—atopic dermatitis	2.63e-05	0.00136	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TAC1—atopic dermatitis	2.52e-05	0.00131	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NPS—atopic dermatitis	2.52e-05	0.00131	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCR3—atopic dermatitis	2.48e-05	0.00128	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL5—atopic dermatitis	2.35e-05	0.00122	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CXCL8—atopic dermatitis	2.18e-05	0.00113	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL10—atopic dermatitis	2e-05	0.00104	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GLB1—atopic dermatitis	1.91e-05	0.000987	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.85e-05	0.000955	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADSL—atopic dermatitis	1.83e-05	0.000946	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.75e-05	0.000906	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL5—atopic dermatitis	1.72e-05	0.000892	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IL2—atopic dermatitis	1.67e-05	0.000865	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARA—atopic dermatitis	1.66e-05	0.000859	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NGF—atopic dermatitis	1.6e-05	0.000826	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL8—atopic dermatitis	1.59e-05	0.000822	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR5—atopic dermatitis	1.55e-05	0.000804	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL2—atopic dermatitis	1.52e-05	0.000786	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.46e-05	0.000756	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARA—atopic dermatitis	1.35e-05	0.000698	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.32e-05	0.000684	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NFKBIA—atopic dermatitis	1.32e-05	0.000681	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL8—atopic dermatitis	9.38e-06	0.000486	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL2—atopic dermatitis	8.97e-06	0.000464	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—atopic dermatitis	8.92e-06	0.000462	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MAPK8—atopic dermatitis	8.25e-06	0.000427	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARA—atopic dermatitis	6.19e-06	0.00032	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—atopic dermatitis	5.27e-06	0.000273	CbGpPWpGaD
